Literature DB >> 10973633

Role of vascular endothelial growth factor in ovarian physiology and pathology.

E Geva1, R B Jaffe.   

Abstract

OBJECTIVE: To review the current literature on the role of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in ovarian physiology and pathology.
DESIGN: A computerized search was conducted to identify relevant in vitro and in vivo studies published in English. MEDLINE, Current Contents, and the Index Medicus were searched for studies published before January 2000. RESULT(S): VEGF/VPF is an angiogenic factor and a potent mitogen for vascular endothelium. During reproductive life, VEGF/VPF plays a role in the cyclic growth of ovarian follicles and corpus luteum development and maintenance, mediating ovarian angiogenesis. VEGF/VPF expression and secretion are induced by both FSH and LH/hCG receptor-activated pathways. CONCLUSION(S): VEGF/VPF expression and production within the ovary are critical for normal reproductive function. Defects in angiogenesis may contribute to a variety of disorders including anovulation and infertility, pregnancy loss, ovarian hyperstimulation syndrome, and ovarian neoplasms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973633     DOI: 10.1016/s0015-0282(00)00670-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  53 in total

Review 1.  Angiogenesis in the female reproductive organs: pathological implications.

Authors:  Lawrence P Reynolds; Anna T Grazul-Bilska; Dale A Redmer
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

Review 2.  The normal human menstrual cycle.

Authors:  N Chabbert-Buffet; P Bouchard
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

3.  A role for cysteine-rich 61 in the angiogenic switch during the estrous cycle in cows: regulation by prostaglandin F2alpha.

Authors:  Bo Zhang; Paul C W Tsang; Joy L Pate; Marsha A Moses
Journal:  Biol Reprod       Date:  2011-04-13       Impact factor: 4.285

4.  The clinical significance of vascular endothelial growth factor in malignant ascites.

Authors:  Na Zhan; Wei-Guo Dong; Jing Wang
Journal:  Tumour Biol       Date:  2015-10-13

5.  Palmar fasciitis with polyarthritis-associated ovarian cancer: Case report and literature review.

Authors:  Hiroyuki Kajikawa; Takuya Sobajima; Chinatsu Koiwai; Satoshi Ichigo; Hiroshi Takagi; Atsushi Imai
Journal:  Mol Clin Oncol       Date:  2017-11-24

Review 6.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

7.  The regulators of VEGF expression in mouse ovaries.

Authors:  So Young Shin; Ho-Jung Lee; Duck-Sung Ko; Hoi-Chang Lee; Won Il Park
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

8.  Severe ovarian hyperstimulation syndrome leading to ICU admission.

Authors:  R K Singh; Sanjay Singhal; Afzal Azim; A K Baronia
Journal:  Saudi J Anaesth       Date:  2010-01

9.  Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway.

Authors:  Marcela Julio-Pieper; Patricia Lozada; Veronica Tapia; Margarita Vega; Cristián Miranda; David Vantman; Sergio R Ojeda; Carmen Romero
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

10.  A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.

Authors:  Ahmed Abdel-Razik; Nasser Mousa; Hatem Elalfy; Tarek Fouad Sheta; Mahmoud Awad; Mostafa Abdelsalam; Rania Elhelaly; Rasha Elzehery; Nawal S Gouda; Waleed Eldars
Journal:  J Gastrointest Cancer       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.